| Name | Title | Contact Details |
|---|
Orahealth USA is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As part of the state`s premier academic medical center, University of Missouri Health Care offers a full spectrum of care, ranging from primary care to highly specialized, multidisciplinary treatment for patients with the most severe illnesses and injuries. Patients from each of Missouri`s 114 counties are served by approximately 6,000 physicians, nurses and health care professionals at MU Health Care. MU Health Care is a part of University of Missouri Health System, which also includes the MU School of Health Professions, the MU School of Medicine, the MU Sinclair School of Nursing and University Physicians practice plan. University Hospital includes: The Frank L. Mitchell Jr., MD Trauma Center. A nationally accredited Cycle II Chest Pain Center and a nationally accredited Primary Stroke Center, the George D. Peak Memorial Burn and Wound Center. University of Missouri Women`s and Children`s Hospital is Missouri`s only hospital dedicated to women and children. It is the largest pediatric health care facility in mid-Missouri. Ellis Fischel Cancer Center is Missouri`s only hospital dedicated solely to cancer care. Missouri Orthopaedic Institute is the newest and largest freestanding orthopaedic center in mid-Missouri. The Missouri Psychiatric Center offers short-term, intensive inpatient treatment services for adults, adolescents and children at our facility adjacent to University Hospital.
Clark County Health Department is a Martinsville, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Claimpay is a healthcare billing company that combines smart technology with billing expertise to manage a practices entire revenue process.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.